Jump Financial LLC Invests $1.45 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Jump Financial LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 43,100 shares of the company's stock, valued at approximately $1,452,000.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in Option Care Health by 11.8% during the 3rd quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company's stock worth $624,981,000 after acquiring an additional 2,037,162 shares in the last quarter. Third Point LLC lifted its position in shares of Option Care Health by 55.7% during the third quarter. Third Point LLC now owns 5,450,659 shares of the company's stock valued at $176,329,000 after buying an additional 1,950,659 shares during the last quarter. FMR LLC grew its position in shares of Option Care Health by 10.8% in the 3rd quarter. FMR LLC now owns 3,717,299 shares of the company's stock worth $120,255,000 after buying an additional 362,828 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Option Care Health by 15.9% during the 3rd quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company's stock worth $93,698,000 after acquiring an additional 397,627 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Option Care Health by 5.1% during the third quarter. Northern Trust Corp now owns 2,477,480 shares of the company's stock valued at $80,146,000 after acquiring an additional 120,212 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Down 0.7 %

Shares of NASDAQ:OPCH traded down $0.22 during mid-day trading on Thursday, reaching $29.84. 931,131 shares of the company were exchanged, compared to its average volume of 1,309,854. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.39. The firm has a market cap of $5.19 billion, a price-to-earnings ratio of 19.70, a P/E/G ratio of 1.46 and a beta of 1.26. Option Care Health, Inc. has a 1 year low of $26.17 and a 1 year high of $35.74. The firm's 50-day simple moving average is $31.31 and its 200 day simple moving average is $31.38.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business had revenue of $1.15 billion during the quarter, compared to analysts' expectations of $1.10 billion. During the same period in the prior year, the firm posted $0.21 EPS. The business's quarterly revenue was up 12.8% compared to the same quarter last year. Equities research analysts forecast that Option Care Health, Inc. will post 1.19 EPS for the current year.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the stock in a transaction dated Monday, February 26th. The shares were acquired at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on OPCH shares. Jefferies Financial Group increased their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "buy" rating in a report on Monday, March 4th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 24th.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.